Oric Pharmaceuticals CEO Jacob Chacko's 2022 pay falls 37% to $4.4M
Oric Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
Oric Pharmaceuticals reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at Oric Pharmaceuticals received on average a compensation package of $2.7M, a 33% decrease compared to previous year.
Average pay of disclosed executives at Oric Pharmaceuticals
Jacob M. Chacko, Chief Executive Officer, received $4.4M in total, which decreased by 37% compared to 2021. 68% of Chacko's compensation, or $3M, was in option awards. Chacko also received $336K in non-equity incentive plan, $572K in salary, $474K in stock awards, as well as $13K in other compensation.
Dominic Piscitelli, Chief Financial Officer, received a compensation package of $1.9M, which decreased by 25% compared to previous year. 58% of the compensation package, or $1.1M, was in option awards.
Pratik Multani, Chief Medical Officer, earned $1.9M in 2022, a 27% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.